Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
5-hydroxytryptamine receptor 2C | 0 | 2 | 1 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 6 | 1 | 7 |
5-hydroxytryptamine receptor 1B | 0 | 6 | 1 | 7 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 1 | 3 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
TDP1 protein | 20 | 0 | 0 | 20 |
AR protein | 27 | 0 | 0 | 27 |
glucocorticoid receptor [Homo sapiens] | 20 | 0 | 0 | 20 |
estrogen nuclear receptor alpha | 31 | 0 | 0 | 31 |
peroxisome proliferator activated receptor gamma | 13 | 0 | 0 | 13 |
ATP-binding cassette sub-family C member 3 | 0 | 12 | 0 | 12 |
Multidrug resistance-associated protein 4 | 0 | 12 | 0 | 15 |
Bile salt export pump | 0 | 15 | 0 | 15 |
Cellular tumor antigen p53 | 23 | 0 | 0 | 23 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
Prostacyclin receptor | 0 | 4 | 2 | 6 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 5 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 12 | 0 | 13 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 4 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
Microtubule-associated protein tau | 12 | 0 | 0 | 12 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
Smad3 | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 13 | 0 | 0 | 13 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 7 | 0 | 8 |
Carbonic anhydrase 2 | 0 | 7 | 1 | 9 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 0 | 1 | 1 |
pregnane X receptor | 5 | 0 | 0 | 5 |
GLI family zinc finger 3 | 17 | 0 | 0 | 17 |
progesterone receptor | 12 | 0 | 0 | 12 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 13 | 0 | 0 | 13 |
estrogen-related nuclear receptor alpha | 21 | 0 | 0 | 21 |
farnesoid X nuclear receptor | 13 | 0 | 0 | 13 |
pregnane X nuclear receptor | 15 | 0 | 0 | 15 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 12 | 0 | 0 | 12 |
IDH1 | 4 | 0 | 0 | 4 |
aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 12 | 0 | 0 | 12 |
nuclear receptor subfamily 1, group I, member 2 | 5 | 0 | 0 | 5 |
thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 20 | 0 | 0 | 20 |
Voltage-dependent calcium channel gamma-2 subunit | 14 | 0 | 0 | 14 |
Glucocorticoid receptor | 1 | 10 | 4 | 22 |
Glycine receptor subunit alpha-1 | 0 | 10 | 0 | 10 |
Glutamate receptor 2 | 14 | 0 | 0 | 14 |
Glycine receptor subunit beta | 0 | 10 | 0 | 10 |
Glycine receptor subunit alpha-2 | 0 | 10 | 0 | 10 |
Glycine receptor subunit alpha-3 | 0 | 10 | 0 | 10 |
ORF73 | 0 | 0 | 1 | 1 |
RAR-related orphan receptor gamma | 18 | 0 | 0 | 18 |
estrogen receptor 2 (ER beta) | 10 | 0 | 0 | 10 |
nuclear receptor subfamily 1, group I, member 3 | 16 | 0 | 0 | 16 |
retinoic acid nuclear receptor alpha variant 1 | 20 | 0 | 0 | 20 |
retinoid X nuclear receptor alpha | 15 | 0 | 0 | 15 |
peroxisome proliferator-activated receptor delta | 13 | 0 | 0 | 13 |
thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
activating transcription factor 6 | 11 | 0 | 0 | 11 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 13 | 0 | 0 | 13 |
thyroid hormone receptor beta isoform 2 | 19 | 0 | 0 | 19 |
heat shock protein beta-1 | 8 | 0 | 0 | 8 |
aldehyde dehydrogenase 1 family, member A1 | 14 | 0 | 0 | 14 |
Nuclear receptor ROR-gamma | 6 | 0 | 0 | 6 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
GLS protein | 6 | 0 | 0 | 6 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
DNA polymerase beta | 4 | 0 | 0 | 4 |
nuclear receptor ROR-gamma isoform 1 | 11 | 0 | 0 | 11 |
geminin | 15 | 0 | 0 | 15 |
DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
lethal factor (plasmid) | 3 | 0 | 0 | 3 |
Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Adenosine receptor A3 | 0 | 3 | 0 | 3 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 1 | 4 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 4 | 1 | 6 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 3 | 1 | 6 |
Adenosine receptor A2a | 0 | 2 | 1 | 5 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 4 |
Guanine deaminase | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
acetylcholinesterase | 5 | 0 | 0 | 5 |
hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
SMAD family member 2 | 8 | 0 | 0 | 8 |
USP1 protein, partial | 12 | 0 | 0 | 12 |
SMAD family member 3 | 8 | 0 | 0 | 8 |
caspase 7, apoptosis-related cysteine protease | 7 | 0 | 0 | 7 |
67.9K protein | 6 | 0 | 0 | 6 |
caspase-3 | 7 | 0 | 0 | 7 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 13 | 0 | 0 | 13 |
mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
survival motor neuron protein isoform d | 8 | 0 | 0 | 8 |
Caspase-2 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 12 | 0 | 0 | 12 |
Ataxin-2 | 13 | 0 | 0 | 13 |
Luciferase | 7 | 0 | 0 | 7 |
interleukin 8 | 5 | 0 | 0 | 5 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GALC protein | 2 | 0 | 0 | 2 |
Thrombopoietin | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
Histone H2A.x | 8 | 0 | 0 | 8 |
Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 7 | 0 | 0 | 7 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 11 | 0 | 0 | 11 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 16 | 0 | 0 | 16 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
Spike glycoprotein | 9 | 0 | 1 | 10 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 4 |
Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 5 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 9 | 0 | 0 | 9 |
Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
Chain A, Cruzipain | 7 | 0 | 0 | 7 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 5 | 2 | 0 | 7 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 4 | 1 | 5 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 1 | 0 | 3 |
DNA gyrase subunit B | 0 | 1 | 0 | 3 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 2 | 1 | 11 |
Cytochrome P450 2C9 | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit delta | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 2 | 0 | 7 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 2 | 0 | 7 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
Histamine H2 receptor | 4 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 2 | 0 | 7 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 0 | 7 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 2 | 0 | 2 |
GABA theta subunit | 5 | 2 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit epsilon | 5 | 2 | 0 | 7 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
15-lipoxygenase, partial | 6 | 0 | 0 | 6 |
RAD51 | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 4 | 0 | 0 | 4 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
Interferon beta | 9 | 0 | 0 | 9 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 5 |
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | 0 | 1 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 2 |
Pantothenate synthetase | 0 | 1 | 0 | 1 |
Discoidin domain-containing receptor 2 | 0 | 1 | 0 | 1 |
Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
ATAD5 protein, partial | 5 | 0 | 0 | 5 |
regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
G | 6 | 0 | 0 | 6 |
cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 1 | 0 | 2 |
neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 8 | 0 | 8 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
Estrogen receptor | 1 | 7 | 3 | 11 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Integrin beta-3 | 3 | 0 | 0 | 3 |
Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
Integrin alpha-IIb | 3 | 0 | 0 | 3 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 7 | 0 | 7 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 0 | 5 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
D(2) dopamine receptor | 0 | 6 | 0 | 6 |
Androgen receptor | 0 | 6 | 0 | 6 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 9 | 0 | 9 |
Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 5 | 0 | 5 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 6 | 0 | 6 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 2C | 0 | 8 | 0 | 8 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
D(3) dopamine receptor | 0 | 6 | 0 | 6 |
Vasopressin V1a receptor | 0 | 4 | 1 | 5 |
Alpha-synuclein | 2 | 1 | 0 | 3 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 1 | 9 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 6 | 0 | 6 |
Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
Estrogen receptor beta | 1 | 7 | 3 | 11 |
Cysteinyl leukotriene receptor 1 | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 2 | 5 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
Prostaglandin F2-alpha receptor | 0 | 2 | 2 | 4 |
Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 2 | 5 |
Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 3 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 3 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 0 | 1 | 2 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
Protein orai-2 | 0 | 1 | 0 | 1 |
Protein orai-3 | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 3 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
Prothrombin | 0 | 0 | 0 | 1 |
Regulatory protein E2 | 0 | 0 | 1 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Caspase-3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
DNA topoisomerase 2-beta | 0 | 1 | 1 | 8 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Albumin | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 3 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
MPI protein | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
PPM1D protein | 2 | 0 | 0 | 2 |
alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
hypothetical protein, conserved | 2 | 0 | 0 | 2 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
CDK5 | 0 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
flap endonuclease 1 | 4 | 0 | 0 | 4 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
Vif | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 0 | 1 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Toll-like receptor 9 | 0 | 1 | 0 | 1 |
Toll-like receptor 7 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 1 | 0 | 1 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
Fumarate hydratase | 2 | 0 | 0 | 2 |
polyprotein | 2 | 0 | 0 | 2 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
PINK1 | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
Parkin | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Progesterone receptor | 0 | 6 | 2 | 11 |
Mineralocorticoid receptor | 1 | 5 | 2 | 9 |
Androgen receptor | 1 | 6 | 3 | 10 |
Androgen receptor | 0 | 0 | 1 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
dopamine D1 receptor | 3 | 0 | 0 | 3 |
ClpP | 1 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 2 | 4 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 0 | 1 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
arylsulfatase A | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Tegument protein VP16 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 2 | 2 | 5 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Progesterone receptor | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 2 | 2 | 4 |
Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 0 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 0 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 11 | 0 | 0 | 0 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 0 | 1 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
Plasminogen | 0 | 2 | 1 | 3 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |